Genitourinary Cancers | Specialty

Clinical Insights Into Genitourinary Cancer

September 12th 2012

A quick glance at a recent study examining the renal cell carcinoma immunotherapy AGS-003 and the FDA approval of a new noninvasive prostate health index test.

Less Aggressive Surgery Linked to Improved Survival in Older Patients With Kidney Cancer

September 11th 2012

Partial nephrectomy is associated with better overall survival than radical nephrectomy in older patients with early-stage kidney cancer.

Targeted Therapies May Have a Role in Urothelial Cancer

August 28th 2012

Pazopanib has demonstrated activity in a majority of patients with refractory urothelial cancer, providing the first evidence that targeted therapies might have a role in the disease.

Clinical Trials in Progress for Urologic Cancers

August 21st 2012

Summaries of ongoing research underway in bladder, prostate, and renal cancer, intended to stimulate discussion about ongoing clinical trials and to promote collaboration across the urology community.

Desert Harmony: Urological Associates of Southern Arizona Strives for Collaborative Cancer Care

August 13th 2012

At Urological Associates of Southern Arizona, "collaboration" is not just a buzzword, it's part and parcel of the daily practice.

Urology Practice Management Peer Exchange

August 10th 2012

Investigating Large and Small Urology Practice Intricacies

August 10th 2012

Balancing Quality of Care and Costs in Urology Practices

August 10th 2012

Physician Extenders in Urology Practices, Part I

August 10th 2012

Bone Health Programs in Urology Practices, Part II

August 10th 2012

Introduction to Urologists in Cancer Care Peer Exchange

August 10th 2012

Bone Health Programs in Urology Practices, Part I

August 10th 2012

Management of Oncology Care in Urology Practices

August 10th 2012

Physician Extenders in Urology Practices, Part II

August 10th 2012

Studies Support Efficacy of Axitinib as First- and Second-Line Kidney Cancer Treatment

July 30th 2012

Research presented at ASCO 2012 demonstrated the efficacy of axitinib (Inlyta) as both a first- and second-line treatment in patients with metastatic renal cell carcinoma.

Tivozanib Improves PFS Versus Sorafenib in Patients With Renal Cell Carcinoma

July 24th 2012

Tivozanib increased progression-free survival and objective response rate in patients with renal cell carcinoma compared with sorafenib.

The Urology Group: Balancing Expansion With Commitment to the Community

July 13th 2012

In tough economic times when many medical practices have scaled back or even shut down, The Urology Group has flourished.

Dr. Concepcion Discusses Urologists Treating Cancer

July 12th 2012

Dr. Raoul Concepcion, from Urology Associates, PC, Discusses Urologists Treating Cancer.

Bone Health Programs in Urology Practices Deliver Continuity of Care

July 12th 2012

Spurred by the desire to provide the full spectrum of care to prostate cancer patients, urologists across the country have begun to integrate bone health clinics into their practices.

EHRs in the Urology Office

July 11th 2012

The implementation of electronic health records to replace paper charts in urology practices is a recent phenomenon that is picking up some serious momentum.